الفرق بين المراجعتين لصفحة: «قالب:خافضات السكر الفموية ومشابهات الإنسولين»

من موسوعة العلوم العربية
اذهب إلى التنقل اذهب إلى البحث
لا ملخص تعديل
لا ملخص تعديل
 
(مراجعتان متوسطتان بواسطة نفس المستخدم غير معروضتين)
سطر 15: سطر 15:
   | group1 = [[Biguanide]]s
   | group1 = [[Biguanide]]s
   |  list1 =
   |  list1 =
* [[Metformin]]<sup>#</sup>
[[Metformin]]<sup>#</sup> * [[Buformin]]<sup>‡</sup> * [[Phenformin]]<sup>‡</sup>
* [[Buformin]]<sup>‡</sup>
* [[Phenformin]]<sup>‡</sup>


   | group2 = [[Thiazolidinedione|TZD]]s/"glitazones" ([[PPAR modulator|PPAR]])
   | group2 = [[Thiazolidinedione|TZD]]s/"glitazones" ([[PPAR modulator|PPAR]])
   |  list2 =
   |  list2 =
* [[Pioglitazone]]
[[Pioglitazone]] * [[Rivoglitazone]]<sup>†</sup> * [[Rosiglitazone]] * [[Troglitazone]]<sup>‡</sup>
* [[Rivoglitazone]]<sup>†</sup>
* [[Rosiglitazone]]
* [[Troglitazone]]<sup>‡</sup>


   | group3 = [[PPAR_modulator#Dual-PPAR_modulators|Dual PPAR agonist]]
   | group3 = [[PPAR_modulator#Dual-PPAR_modulators|Dual PPAR agonist]]
   |  list3 =
   |  list3 =
* [[Aleglitazar]]<sup>†</sup>
[[Aleglitazar]]<sup>†</sup> * [[Muraglitazar]]<sup>§</sup> * [[Saroglitazar]]<sup>§</sup> * [[Tesaglitazar]]<sup>§</sup>
* [[Muraglitazar]]<sup>§</sup>
* [[Tesaglitazar]]<sup>§</sup>
}}
}}


سطر 43: سطر 36:
| group1 = [[Sulfonylurea]]s
| group1 = [[Sulfonylurea]]s
| list1  =
| list1  =
* ''[[Sulfonylurea#First generation|1st generation]]'': [[Acetohexamide]]
''[[Sulfonylurea#First generation|1st generation]]'':  
* [[Carbutamide]]
[[Acetohexamide]] * [[Carbutamide]] * [[Chlorpropamide]] * [[Metahexamide]] * [[Tolbutamide]] * [[Tolazamide]]
* [[Chlorpropamide]]
* [[Metahexamide]]
* [[Tolbutamide]]
* [[Tolazamide]]


''[[Sulfonylurea#Second generation|2nd generation]]'': [[Glibenclamide|Glibenclamide (Glyburide)]]<sup>#</sup>
''[[Sulfonylurea#Second generation|2nd generation]]'': [[Glibenclamide|Glibenclamide (Glyburide)]]<sup>#</sup>
* [[Glibornuride]]
[[Glibornuride]] * [[Glipizide]] * [[Gliquidone]] * [[Glisoxepide]] * [[Glyclopyramide]] * [[Glimepiride]] * [[Gliclazide]]
* [[Glipizide]]
* [[Gliquidone]]
* [[Glisoxepide]]
* [[Glyclopyramide]]  
* [[Glimepiride]]  
* [[Gliclazide]]


| group2 = [[Meglitinide]]s/"glinides"  
| group2 = [[Meglitinide]]s/"glinides"  
|  list2 =
|  list2 =
* [[Nateglinide]]
[[Nateglinide]] * [[Repaglinide]] * [[Mitiglinide]]
* [[Repaglinide]]
* [[Mitiglinide]]


}}  
}}  
سطر 69: سطر 50:
| group3 = [[Glucagon-like peptide-1 agonist|GLP-1 agonists]]
| group3 = [[Glucagon-like peptide-1 agonist|GLP-1 agonists]]
|  list3 =
|  list3 =
* [[Exenatide]]
[[Exenatide]] * [[Liraglutide]] * [[Taspoglutide]]<sup>†</sup> * [[Albiglutide]]<sup>†</sup> * [[Lixisenatide]]
* [[Liraglutide]]
* [[Taspoglutide]]<sup>†</sup>
* [[Albiglutide]]<sup>†</sup>
* [[Lixisenatide]]


   | group4 = [[Dipeptidyl peptidase-4 inhibitor|DPP-4 inhibitor]]s
   | group4 = [[Dipeptidyl peptidase-4 inhibitor|DPP-4 inhibitor]]s
   |  list4 =
   |  list4 =
* [[Alogliptin]]<sup>†</sup>
[[Alogliptin]]<sup>†</sup> * [[Gemigliptin]] * [[Linagliptin]] * [[Saxagliptin]] * [[Sitagliptin]] * [[Vildagliptin]]
* [[Gemigliptin]]
* [[Linagliptin]]
* [[Saxagliptin]]
* [[Sitagliptin]]
* [[Vildagliptin]]


}}
}}
سطر 88: سطر 60:
| group3 = [[Insulin analog|Analog]]s/other insulins
| group3 = [[Insulin analog|Analog]]s/other insulins
|  list3 =
|  list3 =
* ''fast-acting'' ([[Insulin lispro]]
''fast-acting'' ([[Insulin lispro]] * [[Insulin aspart]] * [[Insulin glulisine]]) * '' short-acting'' ([[Insulin therapy|Regular insulin]]) * ''long-acting'' ([[Insulin glargine]] * [[Insulin detemir]] * [[NPH insulin]]) * ''ultra-long-acting'' ([[Insulin degludec]]<sup>†</sup>) * ''inhalable'' [[Inhalable insulin|Exubera]]<sup>‡</sup>
* [[Insulin aspart]]
* [[Insulin glulisine]])
* '' short-acting'' ([[Insulin therapy|Regular insulin]])
* ''long-acting'' ([[Insulin glargine]]
* [[Insulin detemir]]
* [[NPH insulin]])
* ''ultra-long-acting'' ([[Insulin degludec]]<sup>†</sup>)
* ''inhalable'' [[Inhalable insulin|Exubera]]<sup>‡</sup>


}}
}}
سطر 106: سطر 70:
| group3 = [[Alpha-glucosidase inhibitor]]s
| group3 = [[Alpha-glucosidase inhibitor]]s
|  list3 =
|  list3 =
* [[Acarbose]]
[[Acarbose]] * [[Miglitol]] * [[Voglibose]]
* [[Miglitol]]
* [[Voglibose]]


   | group8 = [[Amylin]] analog
   | group8 = [[Amylin]] analog
   |  list8 =
   |  list8 =
* [[Pramlintide]]
[[Pramlintide]]


   | group11 = [[Sodium-glucose transport proteins|SGLT2]] inhibitors
   | group11 = [[Sodium-glucose transport proteins|SGLT2]] inhibitors
   |  list11 =
   |  list11 =
* [[Canagliflozin]]<sup>†</sup>
[[Canagliflozin]]<sup>†</sup> * [[Dapagliflozin]]<sup>†</sup> * [[Tofogliflozin]]<sup>†</sup> * [[Empagliflozin]]<sup>†</sup> * [[Remogliflozin etabonate|Remogliflozin]]<sup>§</sup> * [[Sergliflozin etabonate|Sergliflozin]]<sup>§</sup>
* [[Dapagliflozin]]<sup>†</sup>
* [[Empagliflozin]]<sup>†</sup>
* [[Remogliflozin etabonate|Remogliflozin]]<sup>§</sup>
* [[Sergliflozin etabonate|Sergliflozin]]<sup>§</sup>


   | group12 = Other
   | group12 = Other
   |  list12 =
   |  list12 =
* [[Benfluorex]]<sup>‡</sup>
[[Benfluorex]]<sup>‡</sup> * [[Tolrestat]]<sup>‡</sup>
* [[Tolrestat]]<sup>‡</sup>


}}
}}
سطر 137: سطر 94:


<noinclude>
<noinclude>
[[Category:Anti-diabetic drugs]]
[[تصنيف:جداول تصفح الأدوية]]
[[تصنيف:جداول تصفح الأدوية|{{PAGENAME}}]]
</noinclude>
</noinclude>
* '''[http://en.wikipedia.org/wiki/Category:Anti-diabetic_drugs انظر مجموعة مقالات خافضات السكر / ويكيبيديا EN]'''

المراجعة الحالية بتاريخ 15:57، 1 نوفمبر 2013

مجلوبة من «http://www.arabsciencepedia.org/w/index.php?title=قالب:خافضات_السكر_الفموية_ومشابهات_الإنسولين&oldid=33338»